These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1493897)

  • 1. [Hepatitis B virus vaccine. Evaluation and perspectives].
    Degos F
    Gastroenterol Clin Biol; 1992; 16(12):927-31. PubMed ID: 1493897
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
    Yap SF
    Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China.
    Liang X; Bi S; Yang W; Wang L; Cui G; Cui F; Zhang Y; Liu J; Gong X; Chen Y; Wang F; Zheng H; Wang F; Guo J; Jia Z; Ma J; Wang H; Luo H; Li L; Jin S; Hadler SC; Wang Y
    J Infect Dis; 2009 Jul; 200(1):39-47. PubMed ID: 19469708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production.
    Zuckerman JN
    J Med Virol; 1996 Dec; 50(4):283-8. PubMed ID: 8950683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pediatrician and the hepatitis B vaccine].
    Mussa GC; Silvestro L; Mussa F
    Minerva Pediatr; 1994 Nov; 46(11):475-80. PubMed ID: 7870007
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen.
    Olde C; Garcia M
    J CANNT; 1998; 8(4):20-1. PubMed ID: 10196927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients.
    Navarro JF; Teruel JL; Mateos M; Ortuño J
    Clin Nephrol; 1994 Feb; 41(2):113-6. PubMed ID: 8004827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
    Idilman R; Colantoni A; De Maria N; Ustun C; Sam R; Ing TS; Akan H; Koc H; Van Thiel DH
    Hepatogastroenterology; 2003; 50(49):217-21. PubMed ID: 12630026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemiological effect of hepatitis B immunization among newborn babies in Beijing].
    Gong XH; Liu LR; Jia L; Li YH; Xing YL; Wang QY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):201-2. PubMed ID: 12716513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases.
    Di Paolo D; Lenci I; Trinito MO; Tisone G; Angelico M
    Dig Liver Dis; 2005 Oct; 37(10):793-8. PubMed ID: 16024302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of indigenous recombinant hepatitis B vaccine in infants following a 0, 1, 2-month vaccination schedule.
    Kumar TS; Abraham P; Raghuraman S; Cherian T
    Indian Pediatr; 2000 Jan; 37(1):75-80. PubMed ID: 10745392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.